prices for glp-1 drugs The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Novo's GLP-1s Highlight List as

By law, Medicare Part D cannot cover drugs prescribed strictly for weight losswhich is why a GLP-1 may be covered for a Medicare patient with type 2 diabetes but not for obesity alone

Data availability The data supporting the conclusions of this article will be made available by the authors, without undue reservation

doi: 10.2147/PPA.S277676 [DOI] [PMC free article] [PubMed] [Google Scholar] 39.McCoy RG, Van Houten HK, Deng Y, et al

And they say the global market is going to reach $71 billion by 2032 with Novo and Eli Lilly each accounting for 45% of its sales

Currently, no reliable estimates of the compounding market for these drugs exist

Your commercial (private) insurance covers the drug